- Investing Ideas
- /
- Global Biotech Breakthroughs
Global Biotech Breakthroughs
Results
84
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
84 companies
Invivyd
Market Cap: US$91.2m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
IVVD
US$0.75
7D
-3.6%
1Y
-61.2%
Devyser Diagnostics
Market Cap: SEK 1.7b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 100.00
7D
-5.7%
1Y
-2.4%
Everest Medicines
Market Cap: HK$13.9b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$42.70
7D
-4.0%
1Y
85.2%
Aroa Biosurgery
Market Cap: AU$155.2m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.45
7D
2.3%
1Y
-8.2%
Beijing Wantai Biological Pharmacy Enterprise
Market Cap: CN¥86.2b
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
CN¥68.10
7D
1.1%
1Y
6.7%
Oryzon Genomics
Market Cap: €207.3m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.
ORY
€2.68
7D
0.9%
1Y
39.8%
Unicycive Therapeutics
Market Cap: US$65.7m
A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.
UNCY
US$0.55
7D
-7.2%
1Y
-41.5%
BeiGene
Market Cap: US$28.3b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$241.43
7D
5.7%
1Y
58.1%
Egetis Therapeutics
Market Cap: SEK 1.1b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 3.03
7D
-7.1%
1Y
-61.6%
Rhythm Pharmaceuticals
Market Cap: US$3.9b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$62.36
7D
4.1%
1Y
69.6%
Quoin Pharmaceuticals
Market Cap: US$5.0m
A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
QNRX
US$8.90
7D
15.6%
1Y
-65.6%
Vertex Pharmaceuticals
Market Cap: US$111.5b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$436.00
7D
-0.6%
1Y
-4.6%
Anavex Life Sciences
Market Cap: US$654.8m
A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.
AVXL
US$7.53
7D
-9.5%
1Y
88.3%
SELLAS Life Sciences Group
Market Cap: US$159.9m
A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.
SLS
US$1.89
7D
16.0%
1Y
35.0%
Active Biotech
Market Cap: SEK 296.5m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.24
7D
93.1%
1Y
-50.7%
BioRestorative Therapies
Market Cap: US$12.0m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.66
7D
3.1%
1Y
28.7%
CanSino Biologics
Market Cap: HK$11.6b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$33.25
7D
0.6%
1Y
50.8%
Japan Tissue Engineering
Market Cap: JP¥22.5b
Engages in the regenerative medicine business in Japan.
7774
JP¥555.00
7D
-4.0%
1Y
-10.9%
Savara
Market Cap: US$617.3m
A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.
SVRA
US$2.84
7D
-7.5%
1Y
-30.4%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł164.6m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł35.30
7D
3.5%
1Y
-53.6%
Mendus
Market Cap: SEK 258.8m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.14
7D
-5.7%
1Y
-46.1%
Amicus Therapeutics
Market Cap: US$1.9b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$6.22
7D
-3.3%
1Y
-35.6%
Day One Biopharmaceuticals
Market Cap: US$635.5m
A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.
DAWN
US$6.27
7D
0.3%
1Y
-54.5%
MaaT Pharma
Market Cap: €78.8m
A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.
MAAT
€4.90
7D
-2.0%
1Y
-38.8%
Sierra Oncology
Market Cap: US$1.3b
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.
SRRA
US$54.99
7D
0.06%
1Y
179.4%
TYK Medicines
Market Cap: HK$8.1b
A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.
2410
HK$21.95
7D
-7.2%
1Y
n/a
PYC Therapeutics
Market Cap: AU$699.9m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.20
7D
-3.2%
1Y
0%
Suzhou Zelgen BiopharmaceuticalsLtd
Market Cap: CN¥25.4b
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
688266
CN¥96.12
7D
4.1%
1Y
81.7%
Cutia Therapeutics
Market Cap: HK$2.8b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$8.65
7D
34.3%
1Y
8.8%
Arcturus Therapeutics Holdings
Market Cap: US$347.1m
Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
ARCT
US$12.20
7D
4.7%
1Y
-59.9%
Alector
Market Cap: US$131.0m
A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.
ALEC
US$1.24
7D
1.6%
1Y
-75.2%
Zai Lab
Market Cap: US$3.5b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB
US$31.32
7D
1.3%
1Y
74.8%
Scholar Rock Holding
Market Cap: US$2.9b
A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
SRRK
US$30.00
7D
-1.8%
1Y
181.2%
Geron
Market Cap: US$942.6m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.45
7D
14.2%
1Y
-58.3%
Valneva
Market Cap: €464.7m
A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
VLA
€2.78
7D
-3.1%
1Y
-28.4%
Initiator Pharma
Market Cap: SEK 218.5m
A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.
INIT
SEK 3.89
7D
-33.4%
1Y
-56.7%